AAAAAA
Results:
1-23
|
Results: 23
Authors:
Foss, B
Ulvestad, E
Hervig, T
Bruserud, O
Citation: B. Foss et al., Effects of cytarabine and various anthracyclins on platelet activation: Characterization of in vitro effects and their possible clinical relevance inacute myelogenous leukemia, INT J CANC, 97(1), 2002, pp. 106-114
Authors:
Ulvestad, E
Citation: E. Ulvestad, Performance characteristics and clinical utility of a hybrid ELISA for detection of ANA, APMIS, 109(3), 2001, pp. 217-222
Authors:
Foss, B
Ulvestad, E
Bruserud, O
Citation: B. Foss et al., Platelet-derived growth factor (PDGF) in human acute myelogenous leukemia:PDGF receptor expression, endogenous PDGF release and responsiveness to exogenous PDGF isoforms by in vitro cultured acute myelogenous leukemia blasts, EUR J HAEMA, 66(6), 2001, pp. 365-376
Authors:
Ulvestad, E
Citation: E. Ulvestad, Anti-cardiolipin autoantbodies and pulmonary embolism - Reply, SC J RHEUM, 30(3), 2001, pp. 178-179
Authors:
Ulvestad, E
Kanestrom, A
Madland, TM
Thomassen, E
Haga, HJ
Citation: E. Ulvestad et al., Clinical utility of diagnostic tests for rheumatoid factor, SC J RHEUM, 30(2), 2001, pp. 87-91
Authors:
Ulvestad, E
Berentsen, S
Mollnes, TE
Citation: E. Ulvestad et al., Acute phase haemolysis in chronic cold agglutinin disease, SC J IMMUN, 54(1-2), 2001, pp. 239-242
Authors:
Ulvestad, E
Kanestrom, A
Sonsteby, LJ
Jureen, R
Omland, T
Edvardsen, B
Lundervik, J
Kristoffersen, E
Van Dam, AP
Citation: E. Ulvestad et al., Diagnostic and biological significance of anti-p41 IgM antibodies against Borrelia burgdorferi, SC J IMMUN, 53(4), 2001, pp. 416-421
Authors:
Berentsen, S
Tjonnfjord, GE
Brudevold, R
Gjertsen, BT
Langholm, R
Lokkevik, E
Sorbo, JH
Ulvestad, E
Citation: S. Berentsen et al., Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease, BR J HAEM, 115(1), 2001, pp. 79-83
Authors:
Bruserud, O
Ulvestad, E
Citation: O. Bruserud et E. Ulvestad, Cytokine responsiveness of mitogen-activated T cells derived from acute leukemia patients with chemotherapy-induced leukopenia, J INTERF CY, 20(11), 2000, pp. 947-954
Authors:
Berentsen, S
Tjonnfjord, GE
Shammas, FV
Bergheim, J
Hammerstrom, J
Langholm, R
Ulvestad, E
Citation: S. Berentsen et al., No response to cladribine in five patients with chronic cold agglutinin disease, EUR J HAEMA, 65(1), 2000, pp. 88-90
Authors:
Bruserud, O
Ulvestad, E
Citation: O. Bruserud et E. Ulvestad, Soluble Fas/Apo-1 (CD95) levels during T cell activation in the presence of acute myelogenous leukemia accessory cells; contributions from local release and variations in systemic levels, CANCER IMMU, 49(7), 2000, pp. 377-387
Authors:
Ulvestad, E
Kanestrom, A
Tengner, P
Gjerde, S
Sundal, J
Haga, HJ
Citation: E. Ulvestad et al., Anti-cardiolipin autoantibodies and pulmonary embolism - A case for a common cause, SC J RHEUM, 29(5), 2000, pp. 330-333
Authors:
Ulvestad, E
Kanestrom, A
Madland, TM
Thomassen, E
Haga, HJ
Vollset, SE
Citation: E. Ulvestad et al., Evaluation of diagnostic tests for antinuclear antibodies in rheumatological practice, SC J IMMUN, 52(3), 2000, pp. 309-315
Authors:
Raknes, G
Fernandes, JA
Pandey, JP
Myhr, KM
Ulvestad, E
Nyland, H
Vedeler, CA
Citation: G. Raknes et al., IgG allotypes and subclasses in Norwegian patients with multiple sclerosis, J NEUR SCI, 175(2), 2000, pp. 111-115
Authors:
Visted, T
Thorsen, J
Thorsen, F
Read, TA
Ulvestad, E
Engebraaten, O
Sorensen, D
Yla-Herttuala, S
Tyynela, K
Rucklidge, G
Edvardsen, K
Bjerkvig, R
Lund-Johansen, M
Citation: T. Visted et al., lacZ-neoR transfected glioma cells in syngeneic rats: Growth pattern and characterization of the host immune response against cells transplanted inside and outside the CNS, INT J CANC, 85(2), 2000, pp. 228-235
Authors:
Bruserud, O
Ulvestad, E
Citation: O. Bruserud et E. Ulvestad, Acute myelogenous leukemia blasts as accessory cells during in vitro T lymphocyte activation, CELL IMMUN, 206(1), 2000, pp. 36-50
Authors:
Bruserud, O
von Volkman, HL
Ulvestad, E
Citation: O. Bruserud et al., The cellular immune system of patients with acute leukemia and severe chemotherapy-induced leukopenia: Characterization of T lymphocyte subsets responsive to IL-16 and IL-17, ACT HAEMAT, 104(2-3), 2000, pp. 80-91
Authors:
Bruserud, O
Ulvestad, E
Citation: O. Bruserud et E. Ulvestad, Effects of gamma-irradiation on acute myelogenous leukemia blasts: In vitro studies of proliferation, constitutive cytokine secretion, and accessory cell function during T cell activation, J HEMATH ST, 8(4), 1999, pp. 431-441
Authors:
Ulvestad, E
Berentsen, S
Bo, K
Shammas, FV
Citation: E. Ulvestad et al., Clinical immunology of chronic cold agglutinin disease, EUR J HAEMA, 63(4), 1999, pp. 259-266
Authors:
Read, TA
Stensvaag, V
Vindenes, H
Ulvestad, E
Bjerkvig, R
Thorsen, F
Citation: Ta. Read et al., Cells encapsulated in alginate: A potential system for delivery of recombinant proteins to malignant brain tumours, INT J DEV N, 17(5-6), 1999, pp. 653-663
Authors:
Haga, HJ
Hulten, B
Bolstad, AI
Ulvestad, E
Jonsson, R
Citation: Hj. Haga et al., Reliability and sensitivity of diagnostic tests for primary Sjogren's syndrome, J RHEUMATOL, 26(3), 1999, pp. 604-608
Authors:
Bruserud, O
Ulvestad, E
Citation: O. Bruserud et E. Ulvestad, Expression and release of adhesion molecules by human acute myelogenous leukemia blasts, LEUK RES, 23(2), 1999, pp. 149-157
Authors:
Bruserud, O
Foss, B
Ulvestad, E
Hervig, T
Citation: O. Bruserud et al., Effects of acute myelogenous leukemia blasts on platelet release of soluble P-selectin and platelet-derived growth factor, PLATELETS, 9(6), 1998, pp. 352-358
Risultati:
1-23
|